AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
AcelRx Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: June 3, 2022
AcelRx Pharmaceuticals reported fiscal year 2021 executive compensation information on June 3, 2022.
In 2021, three executives at AcelRx Pharmaceuticals received on average a compensation package of $1.5M, a 26% increase compared to previous year.
Average pay of disclosed executives at AcelRx Pharmaceuticals
Vincent J. Angotti, Chief Executive Officer, received $2.4M in total, which increased by 39% compared to 2020. 47% of Angotti's compensation, or $1.2M, was in option awards. Angotti also received $267K in non-equity incentive plan, $637K in salary, $376K in stock awards, as well as $11K in other compensation.
Pamela P. Palmer, Chief Medical Officer, received a compensation package of $1.1M, which increased by 13% compared to previous year. 47% of the compensation package, or $511K, was in salary.
Raffi Asadorian, Chief Financial Officer, earned $1M in 2021, a 15% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on June 3, 2022.